mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
8e-07 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-06 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
AMG-706 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-05 |